DIOXOLANE ANALOGS FOR IMPROVED INTER-CELLULAR DELIVERY
申请人:Shire BioChem Inc.
公开号:EP1324997A2
公开(公告)日:2003-07-09
[EN] DIOXOLANE ANALOGS FOR IMPROVED INTER-CELLULAR DELIVERY<br/>[FR] ANALOGUES DE DIOXOLANE POUR ADMINISTRATION INTERCELLULAIRE AMELIOREE
申请人:SHIRE BIOCHEM INC
公开号:WO2002030922A2
公开(公告)日:2002-04-18
Compounds having the following formula:wherein: R1 is for example, H;C1-24 alkyl;C2-24 alkenyl;C6-24aryl;C5-20 heteroaromatic ring; orC3-20 non aromatic ring; R2 is a purine of pyrimidine group; or a pharmaceutically acceptable salt thereof, are useful in treating a patient having cancer.
Dioxolane analogs for improved inter-cellular delivery
申请人:Shire BioChem Inc.
公开号:US20030013660A1
公开(公告)日:2003-01-16
Dioxolane analogs of the following formula:
1
wherein R1 and R2 are defined herein, are useful in the treatment of cancer. For example, the compounds can be used to treat patients with cancer in which the cancer cells are deficient in nucleoside or nucleoside base transporters.